Recombinant multi-species NAP2/PPBP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NAP2/PPBP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a platelet-derived growth factor that belongs to the CXC chemokine family. This growth factor is a potent chemoattractant and activator of neutrophils. It has been shown to stimulate various cellular processes including DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and synthesis of hyaluronic acid and sulfated glycosaminoglycan. It also stimulates the formation and secretion of plasminogen activator by synovial cells. The protein also is an antimicrobial protein with bactericidal and antifungal activity. [provided by RefSeq, Nov 2014]
The Alternative Names of target: B-TG1,Beta-TG,C-X-C motif chemokine 7,CTAP-III,CTAP3,CTAPIII,CXCL7,LA-PF4,LDGF,Leukocyte-derived growth factor (LDGF),MDGF,Macrophage-derived growth factor (MDGF),NAP-2,NAP2,PBP,PPBP,Platelet basic protein,SCYB7,Small-inducible cytokine B7,TC1,TC2,TGB,TGB1,THBGB,THBGB1

Target products collectionGo to NAP2/PPBP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0421-Ag-1/ GM-Tg-hg-SE0421-Ag-2 Human NAP2/PPBP protein Human
GM-Tg-rg-SE0421-Ag-1/ GM-Tg-rg-SE0421-Ag-2 Rat NAP2/PPBP protein Rat
GM-Tg-mg-SE0421-Ag-1/ GM-Tg-mg-SE0421-Ag-2 Mouse NAP2/PPBP protein Mouse
GM-Tg-cynog-SE0421-Ag-1/ GM-Tg-cynog-SE0421-Ag-2 Cynomolgus/Rhesus macaque NAP2/PPBP protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0421-Ag-1/ GM-Tg-felg-SE0421-Ag-2 Feline NAP2/PPBP protein Feline
GM-Tg-cang-SE0421-Ag-1/ GM-Tg-cang-SE0421-Ag-2 Canine NAP2/PPBP protein Canine
GM-Tg-bovg-SE0421-Ag-1/ GM-Tg-bovg-SE0421-Ag-2 Bovine NAP2/PPBP protein Bovine
GM-Tg-equg-SE0421-Ag-1/ GM-Tg-equg-SE0421-Ag-2 Equine NAP2/PPBP protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0421-Ag-1/ GM-Tg-hg-SE0421-Ag-2; GM-Tg-rg-SE0421-Ag-1/ GM-Tg-rg-SE0421-Ag-2;
GM-Tg-mg-SE0421-Ag-1/ GM-Tg-mg-SE0421-Ag-2; GM-Tg-cynog-SE0421-Ag-1/ GM-Tg-cynog-SE0421-Ag-2;
GM-Tg-felg-SE0421-Ag-1/ GM-Tg-felg-SE0421-Ag-2; GM-Tg-cang-SE0421-Ag-1/ GM-Tg-cang-SE0421-Ag-2;
GM-Tg-bovg-SE0421-Ag-1/ GM-Tg-bovg-SE0421-Ag-2; GM-Tg-equg-SE0421-Ag-1/ GM-Tg-equg-SE0421-Ag-2
Products Name NAP2/PPBP protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NAP2/PPBP
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NAP2/PPBP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.